Search results

1. The effect of Tinnitus Retraining Therapy (TRT) and neurofeedback training on neural repesentation of tinnitus accompani…

Principal investigator: dr Monika Zofia Lewandowska

Instytut Fizjologii i Patologii Słuchu

Call: SONATA 2, Panel: NZ4

2. Efektywność nowatorskiej terapii inhibitorami JAK u pacjentów z reumatoidalnym zapaleniem stawów w odniesieniu do profil…

Principal investigator: Sylwia Anna Biały

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: PRELUDIUM 22, Panel: NZ5

3. Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic…

Principal investigator: dr hab. Janusz Marcin Dąbrowski

Uniwersytet Jagielloński, Wydział Chemii

Call: OPUS 19, Panel: NZ7

4. Biokoniugaty radioaktywnych nanocząstek platyny do celowanej terapii elektronami Auger

Principal investigator: prof. Aleksander Józef Bilewicz

Instytut Chemii i Techniki Jądrowej

Call: OPUS 18, Panel: ST4

5. Regulation of epithelial to mesenchymal transition and therapy resistance to antitumor therapies by MCPIP1

Principal investigator: dr hab. Katarzyna Miękus

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: SONATA BIS 7, Panel: NZ5

6. Silicon and titanium as beam-activated tumour tracers for online proton therapy monitoring

Principal investigator: Magdalena Maria Kołodziej

Uniwersytet Jagielloński, Wydział Fizyki, Astronomii i Informatyki Stosowanej

Call: PRELUDIUM 22, Panel: ST2

7. New approach to glioblastoma adoptive therapy based on inducible CAR expression system - SynCAR

Principal investigator: dr hab. Radosław Zagożdżon

Warszawski Uniwersytet Medyczny

Call: OPUS 29, Panel: NZ6

8. Where Inhibition is not Enough- Development of Innovative Compounds for Targeted Degradation of Extracellular and Membra…

Principal investigator: dr Marcin Skoreński

Politechnika Wrocławska

Call: OPUS 28 (LAP), Panel: NZ5

9. Hybrid Nanocomposites Based on Gold Nanoparticles as Promising Photoactive Materials for Combined Photothermal/Photodyna…

Principal investigator: dr Paulina Błaszkiewicz

Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum NanoBioMedyczne

Call: SONATINA 7, Panel: ST4

10. Liposomal theranostic agent for magnetic resonance imaging and photodynamic therapy

Principal investigator: dr Paulina Krystyna Skupin-Mrugalska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: SONATA 11, Panel: NZ7

11. Influence of music therapy to improve quality of gait and selected daily live activities in a group of patients with Par…

Principal investigator: Anna Aldona Bukowska

AKADEMIA WYCHOWANIA FIZYCZNEGO IM. BRONISŁAWA CZECHA W KRAKOWIE, Wydział Rehabilitacji Ruchowej

Call: PRELUDIUM 3, Panel: NZ7

12. Efficiency biomarkers in photodynamic therapy against lung cancer

Principal investigator: dr Martyna Krzykawska-Serda

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: PRELUDIUM 2, Panel: NZ4

13. Development of Red-Emitting Chiral Carbon Dots for Advanced Photodynamic Therapy (PDT)

Principal investigator: Patryk Szymaszek

Politechnika Krakowska im. Tadeusza Kościuszki

Call: PRELUDIUM 24, Panel: ST8

14. Synergistic enhancement of reactive oxygen species generation via combination of heavy atom effect with donor-acceptor a…

Principal investigator: Karolina Anna Urbanowicz

Politechnika Warszawska

Call: PRELUDIUM 24, Panel: ST5

15. Simulation of complex biological systems assisted by artificial intelligence: language-controlled model for cancer thera…

Principal investigator: prof. Witold Dzwinel

Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie

Call: OPUS 29, Panel: ST6

16. Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

Principal investigator: Alicja Stanisława Słota

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ7

17. Elimination of IgE-producing cells using next-generation chimeric antigen receptor (CAR)-based therapy

Principal investigator: dr hab. Beata Kaleta

Warszawski Uniwersytet Medyczny

Call: OPUS 29, Panel: NZ6

18. New violacein derivatives as candidates for sonodynamic therapy against skin cancer

Principal investigator: dr Daniel Ryszard Ziental

Uniwersytet Przyrodniczy w Poznaniu

Call: SONATINA 9, Panel: NZ7

19. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

Principal investigator: dr Daria Nawrocka

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATINA 9, Panel: NZ6

20. The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

Principal investigator: dr Michał Jerzy Woźniak

Uniwersytet Medyczny w Łodzi

Call: OPUS 28, Panel: NZ7

21. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

Principal investigator: dr Anna Dominika Walczak-Szeffer

Uniwersytet Medyczny w Łodzi

Call: SONATA 20, Panel: NZ5

22. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

Principal investigator: dr Marco Deiana

Politechnika Wrocławska

Call: SONATA BIS 14, Panel: NZ5

23. Synthesis of novel hybrid nanomaterials based on fullerene scaffold for photodynamic therapy of cancer

Principal investigator: Dominik Jakub Dreszer

UNIWERSYTET ŚLĄSKI

Call: PRELUDIUM 23, Panel: NZ7

24. Precision double strike against non-small cell lung cancer. Insights into multidirectional therapies and the landscape o…

Principal investigator: dr Katarzyna Anna Malarz

Politechnika Śląska

Call: OPUS 27, Panel: NZ5

25. Identification and characterization of omics profiles in patients' serum during anti-CD19 CAR-T cell therapy

Principal investigator: Jaromir Bartosz Tomasik

Warszawski Uniwersytet Medyczny

Call: PRELUDIUM 23, Panel: NZ5

26. Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing t…

Principal investigator: dr hab. Damian Nestor Plażuk

Uniwersytet Łódzki

Call: OPUS 27, Panel: NZ7

27. Miniature CRISPR/Cas nucleases for upregulation of utrophin expression: a novel approach for mutation-independent therap…

Principal investigator: prof. Józef Dulak

Uniwersytet Jagielloński

Call: DAINA 3, Panel: NZ3

28. Potential pharmacological strategies aimed at alleviating cognitive dysfunctions accompanying oncological therapy while …

Principal investigator: dr hab. Joanna Monika Wierońska

Instytut Farmakologii PAN

Call: OPUS 26, Panel: NZ5

29. LighTEM - light-induced in situ electron microscopy and its application in the imaging of light-matter interactions on t…

Principal investigator: dr hab. Andrzej Marek Żak

Politechnika Wrocławska

Call: SONATA 19, Panel: ST11

30. Anticancer potential of TMPyP4 porphyrin in breast cancer photodynamic therapy and evaluation of the treatment safety

Principal investigator: prof. Błażej Rubiś

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: OPUS 25, Panel: NZ7

31. Cuproptosis, a novel pathway of regulated cell death as a therapeutic target in treatment-naïve and targeted therapy-res…

Principal investigator: dr hab. Mariusz Łukasz Hartman

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: OPUS 25, Panel: NZ5

32. Targeting Energy Metabolism for Precision Cancer Therapy: Novel Inhibitors of LDH-A and PDK1 as Potential Strategies to …

Principal investigator: Marika Anna Frańczak

Gdański Uniwersytet Medyczny, Wydział Lekarski

Call: PRELUDIUM 22, Panel: NZ7

33. Unveiling the molecular signature underlying resistance to CD19 CAR-T therapy in malignant cells.

Principal investigator: Marta Krawczyk

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: PRELUDIUM 22, Panel: NZ7

34. Research on the preparation of new, hydrogel nanosystems for targeted therapy of colorectal cancer

Principal investigator: dr Urszula Helena Piotrowska

Warszawski Uniwersytet Medyczny

Call: SONATA 18, Panel: NZ7

35. Investigating the role of fibroblast growth factor receptors and STAT transcription factors in the targeted therapy of a…

Principal investigator: prof. Ewa Teresa Marcinkowska

Uniwersytet Wrocławski, Wydział Biotechnologii

Call: PRELUDIUM BIS 4, Panel: NZ5

36. Design and implementation of effective cOmbination of Phages and Antibiotics for improved TheRApy protocols against KLEb…

Principal investigator: prof. Zuzanna - Drulis-Kawa

Uniwersytet Wrocławski, Wydział Nauk Biologicznych

Call: JPIAMR ACTION Call 2022, Panel: NZ6

37. Pancreatic cancer oxygenation as a prognostic marker during anticancer therapy

Principal investigator: dr Martyna Krzykawska-Serda

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: OPUS 23, Panel: NZ5

38. Phagocytic cells as boron carriers in boron neutron capture therapy

Principal investigator: Anna Maria Rudawska

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: PRELUDIUM 21, Panel: NZ5

39. Bioconjugates of 103Pd nanostructures for targeted Auger electron therapy.

Principal investigator: dr hab. Agnieszka Majkowska-Pilip

Instytut Chemii i Techniki Jądrowej

Call: OPUS 23, Panel: ST5

40. Gold nanoparticles functionalized with zinc(II) dipyrromethene and azadipyrromethene complexes as new approach in photod…

Principal investigator: dr Ewelina Wieczorek-Szweda

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Call: SONATINA 6, Panel: ST4

41. The use of genetic analysis of liquid biopsy for predicting and monitoring ofresponse to therapies and tumor evolution i…

Principal investigator: dr Magdalena Olbryt

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Call: OPUS 22, Panel: NZ7

42. Perinuclear AKAP6 signalosome as a new target for gene therapy in ischemic optic neuropathy

Principal investigator: dr hab. Tomasz Boczek

Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

Call: OPUS 22, Panel: NZ4

43. Bioresorbable, electrospun nonwoven as a multi-drug delivery system for a combination glioblastoma therapy

Principal investigator: dr Monika Anna Musiał-Kulik

Centrum Materiałów Polimerowych i Węglowych PAN

Call: SONATA 17, Panel: NZ7

44. Structure-guided design of histone demethylase inhibitors for cancer therapy.

Principal investigator: dr Piotr Henryk Małecki

Instytut Chemii Bioorganicznej PAN

Call: SONATA 17, Panel: NZ7

45. Light-producing, oxygen-delivering, cancer cell-targeted carriers for photosensitisers dedicated for photodynamic therap…

Principal investigator: prof. Marek Arkadiusz Murias

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: OPUS 22, Panel: NZ7

46. Identification and use of natural human-tropic AAVs as vectors for gene therapy applications targeting human liver.

Principal investigator: prof. Leszek Lisowski

Wojskowy Instytut Medyczny

Call: OPUS 21, Panel: NZ5

47. Epigenetic Reprograming and All-trans-Retinoic Acid in Therapy of Myelodysplastic Syndromes

Principal investigator: prof. Artur Zygmunt Zelent

Instytut Genetyki i Hodowli Zwierząt PAN

Call: OPUS 21, Panel: NZ5

48. Synthetic epidermal growth factor receptor inhibitor conjugated with nobel metal nanoparticles as a potential drug for t…

Principal investigator: Shaoshan Mai

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

Call: PRELUDIUM 20, Panel: NZ7

49. Bioconjugates of gold nanoparticles coated by 197/197mHg for Auger electron targeted therapy

Principal investigator: Emilia Teresa Majka

Instytut Chemii i Techniki Jądrowej

Call: PRELUDIUM 20, Panel: ST5

50. The use of artificial miRNAs in the therapy of Huntington's Disease

Principal investigator: dr Anna Kotowska-Zimmer

Instytut Chemii Bioorganicznej PAN

Call: PRELUDIUM 20, Panel: NZ1

Projects search